查看購物車
  • English
  • Japanese
  • Korean
緩釋注射劑市場規模及預測（2021-2034）、全球及區域佔有率、趨勢及成長機會分析報告：製劑包裝、治療應用、給藥途徑及區域細分
市場調查報告書
商品編碼
2042654

緩釋注射劑市場規模及預測（2021-2034）、全球及區域佔有率、趨勢及成長機會分析報告：製劑包裝、治療應用、給藥途徑及區域細分

Long-Term Injectable Drug Delivery Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Formulation Packaging, Therapeutic Application, Route of Administration and Geography
出版日期: | 出版商: The Insight Partners | 英文 327 Pages | 訂單完成後即時交付

價格

預計到2034年，緩釋注射劑市場規模將達到152.1億美元，高於2025年的70.7億美元。該市場預計在2026年至2034年間將以8.9%的複合年成長率成長。市場成長的主要促進因素包括：需要長期藥物治療的慢性病和精神疾病盛行率不斷上升、藥物遞送技術的進步，以及對提高用藥依從性和減少給藥頻率日益成長的需求，所有這些因素都在推動緩釋注射劑的應用。此外，自體免疫疾病和腫瘤領域對長效生物製藥和生物相似藥的需求不斷成長，預計也將在預測期內促進市場發展。然而，研發和生產的複雜性是該市場面臨的障礙之一。

緩釋注射給藥技術的進步徹底革新了藥物治療，實現了藥物在較長時間內的精準持續釋放。先進的藥物遞送系統能夠維持穩定的血漿藥物濃度，同時有效遞送胜肽類、生物製藥和新型mRNA療法等複雜分子。關鍵創新包括：利用可生物分解的聚乳酸-羥基乙酸共聚物（PLGA）進行微膠囊化，形成微球；利用奈米顆粒提高藥物的穩定性和標靶化；注射後固化形成局部儲存的技術；以及能夠持續釋放數月的超長效懸浮液。這些系統克服了傳統口服製劑和短效注射劑的局限性，保護敏感化合物免受快速分解，並確保零級或控釋動力學。

FDA核准的顯著案例清晰地展現了這一進展。例如，Lupron Depot（Leuprolide Acetate）是一種PLGA微球製劑，可在治療前列腺癌和子宮內膜異位症時，持續釋放肽激素促效劑長達六個月。這顯示微囊化技術能夠在降低給藥頻率的同時，穩定地抑制促性腺激素分泌釋放激素的分泌。 Rispedor Consta採用PLGA微球包裹Risperidone，每月一次肌肉注射即可用於治療思覺失調症，與每日遵守用藥相比，提高了患者的依從性。像Eligard（亮丙瑞林）這樣的局部用緩釋製劑，透過在注射後形成並固化皮下植入來控制藥物釋放。奈米顆粒和奈米懸浮液技術是Invega Trinza（棕櫚酸帕利哌酮）等產品的基礎，Invega Trinza是一種超長效製劑，透過奈米晶體工程確保藥物的持續吸收，從而可以每三個月給藥一次，用於治療精神疾病。

這些平台也被應用於生物製藥領域，透過脂質奈米顆粒（LNP）支持mRNA的應用。 LNP能夠保護並遞送疫苗和治療藥物中蛋白質和mRNA等大型、易碎的分子，使其被細胞吸收並持續表達。隨著研究朝著延長作用時間和擴大其在生物製藥和mRNA構建體中的應用範圍不斷深入，這些創新技術有望提高患者用藥的便利性，增強治療效果，並為需要可靠、長期藥物治療的慢性疾病拓展治療選擇。

公司比較分析基於產品系列（產品滿意度、產品功能、可用性）、近期發展（併購和資金籌措、獎項、夥伴關係、合作關係、評估、業務擴張）以及地理分佈，對緩釋注射劑市場進行評估和分類。這有助於決策並加深對競爭格局的理解。本報告深入探討了全球緩釋注射劑市場主要供應商近期的關鍵發展和創新。主要市場參與者包括 Becton Dickinson and Co、Schott AG、Phillips-Medisize、Gerresheimer AG、West Pharmaceutical Services Inc.、Terumo Corp、SHL Medical、Ypsomed Holding AG、Owen Mumford Ltd 和 AptarGroup Inc.。

從即用型（Ready-to-use）包裝的角度來看，緩釋注射劑市場可細分為安瓿、管瓶、藥筒和藥瓶。預計到2025年，管瓶的市佔率將更大。由於管瓶能夠儲存多種注射劑，包括生物製藥和疫苗產品，因此在藥品包裝領域呈現強勁成長。這些產品具有優異的化學穩定性和防污染性能。

從治療應用角度來看，緩釋注射劑市場可細分為糖尿病、腫瘤、自體免疫疾病、心血管疾病、感染疾病、疼痛管理和其他治療應用。預計到2025年，糖尿病領域將佔據更大的市場佔有率。全球糖尿病盛行率的上升、對長效胰島素和GLP-1療法的強勁需求、患者遵守用藥依從性的提高、給藥頻率的降低以及緩釋製劑的持續創新，都是推動該領域成長的因素。

從給藥途徑來看，長效注射藥物市場可分為皮下注射、肌肉注射、靜脈注射和其他給藥途徑。預計到2025年，皮下注射的市佔率將進一步擴大。易於自我給藥、減少臨床監督需求、提高患者舒適度、與生物製藥的兼容性以及穿戴式式和自動注射器系統的日益普及，都是推動皮下注射市場蓬勃發展的重要因素。

從使用角度來看，緩釋注射劑市場可分為一次性注射器和可重複使用注射器。預計到2025年，一次性注射器市場佔有率將更大。便利性、降低交叉感染風險、免維護操作、易用性以及居家照護解決方案需求的不斷成長，都是推動一次性注射器系統普及應用的重要因素。

從終端用戶的角度來看，長效注射劑市場可細分為製藥和生物製藥公司、契約製造(CMO) 以及合約開發和生產公司 (CDMO)。預計到 2025 年，製藥和生物製藥公司將佔據更大的市場佔有率。憑藉強大的研發能力、豐富的藥物研發管線、對長效製劑的大量投資、完善的生產基礎設施以及策略聯盟，製藥和生物製藥公司在市場引入和商業化方面處於主導。

在緩釋注射劑市場營運的公司採用多種有機成長和無機成長策略。有機成長策略主要包括產品上市和核准。無機成長策略則包括收購、聯盟和夥伴關係。這些成長策略使市場參與者能夠拓展業務、擴大地域覆蓋範圍，並促進整體市場成長。此外，收購和夥伴關係也有助於鞏固基本客群和擴展產品系列。以下概述了緩釋注射劑市場主要參與者的關鍵趨勢。

2026年3月，全球領先的先進藥物輸送解決方案供應商SHL Medical AG宣布與全球領先的科學技術公司賽默飛世爾科技（Thermo Fisher Scientific Inc.）建立戰略合作夥伴關係。此次合作將為SHL Medical AG提供從無菌填充、成品加工到最終器械組裝的全流程服務，合作工廠位於美國新澤西州里奇菲爾德的賽默飛世爾科技工廠。

2026年1月，BD和Ipsomed宣布加強合作，共同開發一款5.5 mL的BD Neopak XtraFlow玻璃預填充式注射器，該注射器與Ipsomed的YpsoMate 5.5自動注射器平台相容。這項創新措施旨在透過提高流動效率和縮短注射時間，支持大容量、高黏度生物製藥的自行注射。此舉旨在滿足複雜治療方法中患者對便捷自我給藥方式日益成長的需求。預計用於開發和可行性評估的樣品將於2026年中期提供。

目錄

第1章執行摘要

第2章：緩釋注射藥物遞送系統的市場展望

  • 概述
  • 價值鏈分析
  • 供應鏈分析
  • 波特五力分析
  • PEST分析
  • 主要國家的進出口分析
    • 主要國家的進出口分析
  • 人工智慧（AI）的影響
  • 產品或技術藍圖
  • 永續發展與ESG趨勢
  • 專利分析
  • 法律規範

第3章 競爭情勢

  • 企業標竿分析：依主要公司分類
  • 2025年市佔率分析：依主要公司分類
  • 市場集中度

第4章：緩釋注射劑市場：關鍵產業動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來趨勢
  • 促進因素和抑制因素的影響

第5章：緩釋注射劑市場：全球市場分析

第6章：緩釋注射劑市場收入分析：依製劑包裝（即用型）分類

  • 緩釋注射劑市場預測與分析：依劑型包裝（即用型）分類
    • 安瓿
    • 管瓶
    • 墨水匣
    • 瓶子

第7章：緩釋注射劑市場收入分析：依治療應用分類

  • 緩釋注射劑市場預測與分析：依治療應用分類
    • 糖尿病
    • 腫瘤學
    • 自體免疫疾病
    • 心血管疾病
    • 感染疾病
    • 疼痛管理
    • 其他

第8章：緩釋注射劑市場收入分析：依給藥途徑分類

  • 緩釋注射劑市場預測與分析：依給藥途徑分類
    • 皮下
    • 肌肉內部
    • 靜脈
    • 其他

第9章：緩釋注射藥物遞送市場收入分析：依可用性分類

  • 緩釋注射藥物遞送市場預測與分析：依可用性分類
    • 拋棄式注射器
    • 可重複使用的注射器

第10章：緩釋注射劑市場收入分析：以最終用戶分類

  • 緩釋注射劑市場預測與分析：依最終用戶分類
    • 製藥和生物製藥公司
    • CMO 和 CDMO

第11章：緩釋注射劑市場：區域分析

  • 北美洲
    • 依配方包裝（即用型）
    • 治療用途
    • 透過行政途徑
    • 透過可用性
    • 最終用戶
    • 美國市場
    • 加拿大市場
    • 墨西哥市場
  • 歐洲
    • 德國市場
    • 英國市場
    • 法國市場
    • 西班牙市場
    • 義大利市場
    • 其他歐洲市場
  • 亞太地區
    • 中國市場
    • 日本市場
    • 印度市場
    • 澳洲市場
    • 韓國市場
    • 其他亞太市場
  • 中東和非洲
    • 沙烏地阿拉伯市場
    • 南非市場
    • 阿拉伯聯合大公國市場
    • 其他中東和非洲市場
  • 中美洲和南美洲
    • 巴西市場
    • 阿根廷市場
    • 其他拉丁美洲市場

第12章：緩釋注射劑市場產業趨勢

第13章：緩釋注射劑市場：主要公司概況

  • Becton Dickinson and Co
  • Schott AG
  • Phillips-Medisize
  • Gerresheimer AG
  • West Pharmaceutical Services Inc
  • Terumo Corp
  • SHL Medical
  • Ypsomed Holding AG
  • Owen Mumford Ltd
  • AptarGroup Inc

第14章：其他分析公司列表

第15章附錄

Product Code: TIPRE00043136

The long-term injectable drug delivery market is projected to reach US$ 15.21 billion by 2034 from US$ 7.07 billion in 2025. The market is estimated to register a CAGR of 8.9% during 2026-2034. Major factors driving market growth include the increasing prevalence of chronic and psychiatric disorders requiring long-term pharmacotherapy, advancements in drug delivery technologies, and the rising need to improve medication adherence and reduce dosing frequency that promote long-term injectable drug delivery utilization. Further, increased demand for long-acting biologics and biosimilars in autoimmune and oncology will likely boost the market during the forecast period. However, high complexity of development and manufacturing are among the deterrents of market.

Technological advancements in long-term injectable drug delivery have revolutionized pharmacotherapy by enabling precise, sustained drug release over extended periods. Advanced drug delivery systems maintain stable plasma levels while accommodating complex molecules such as peptides, biologics, and emerging mRNA-based therapies. Key innovations include microencapsulation using biodegradable poly(lactic-co-glycolic acid) (PLGA) polymers to form microspheres, nanoparticles for enhanced stability and targeting, in-situ forming depots that solidify post-injection, and ultra-long-acting suspensions that provide release for months. These systems overcome limitations of traditional oral or short-acting injectables by protecting sensitive compounds from rapid degradation and ensuring zero-order or controlled release kinetics.

Prominent FDA-approved examples illustrate this progress. Lupron Depot (leuprolide acetate), a PLGA microsphere formulation, delivers the peptide hormone agonist for up to six months in prostate cancer and endometriosis treatment, demonstrating how microencapsulation achieves consistent gonadotropin-releasing hormone suppression with reduced dosing frequency. Risperdal Consta employs PLGA microspheres for risperidone, providing monthly intramuscular release for schizophrenia management and improving adherence over daily orals. In-situ forming depots such as Eligard (leuprolide) create a subcutaneous implant upon injection, solidifying to control release. Nanoparticle and nanosuspension technologies power products such as Invega Trinza (paliperidone palmitate), an ultra-long-acting formulation offering three-month dosing for psychiatric disorders via nanocrystal engineering that ensures prolonged absorption.

These platforms also extend to biologics and support mRNA applications through lipid nanoparticles (LNPs), which protect and deliver large, fragile molecules such as proteins or mRNA for vaccines and therapeutics, enabling cellular uptake and sustained expression. As research advances toward even longer durations and broader applicability for biologics and mRNA constructs, these innovations promise greater patient convenience, enhanced therapeutic efficacy, and expanded treatment options for chronic conditions requiring reliable, long-term drug exposure.

The comparative company analysis evaluates and categorizes the Long-Term Injectable Drug Delivery market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global Long-Term Injectable Drug Delivery market. The key market players are Becton Dickinson and Co, Schott AG, Phillips-Medisize, Gerresheimer AG, West Pharmaceutical Services Inc., Terumo Corp, SHL Medical, Ypsomed Holding AG, Owen Mumford Ltd, and AptarGroup Inc.

In terms of formulation packaging (ready-to-use), the long-term injectable drug delivery market is bifurcated into ampoules, vials, cartridges, bottles. The vials segment held a larger market share in 2025. Vials are experiencing strong growth in the formulation packaging segment because they can store diverse injectable medications, which include biologic and vaccine products. The products provide exceptional chemical durability and protection from contamination.

In terms of therapeutic application, the long-term injectable drug delivery market is bifurcated diabetes, oncology, auto-immune disorders, cardiovascular diseases, infectious diseases, pain management, other therapeutic application. The diabetes segment held a larger market share in 2025. Rising global diabetes prevalence, strong demand for long-acting insulin and GLP-1 therapies, improved patient adherence, reduced dosing frequency, and continuous innovation in sustained-release formulations drive segment growth.

In terms of route of administration, the long-term injectable drug delivery market is bifurcated into sub-cutaneous, intramuscular, intravenous, other route of administration. The sub-cutaneous segment held a larger market share in 2025. Ease of self-administration, reduced need for clinical supervision, improved patient comfort, compatibility with biologics, and growing adoption of wearable and auto-injector systems support strong preference for subcutaneous delivery.

In terms of route of usability, the long-term injectable drug delivery market is bifurcated into disposable injectors, re-usable injectors. The disposable injectors segment held a larger market share in 2025. Convenience, reduced risk of cross-contamination, no maintenance requirements, ease of use, and increasing demand for home-based care solutions contribute to higher adoption of disposable injector systems.

Based on end user, the long-term injectable drug delivery market is categorized into pharmaceutical and biopharma companies, CMOs and CDMOs. The pharmaceutical and biopharma companies segment held a larger share of the market in 2025. Strong R&D capabilities, extensive drug pipelines, high investment in long-acting formulations, established manufacturing infrastructure, and strategic collaborations enable pharmaceutical and biopharma companies to lead market adoption and commercialization.

Companies operating in the long-term injectable drug delivery market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses, enhance their geographic presence, and contribute to the overall market growth. Furthermore, acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few significant developments by key Long-Term Injectable Drug Delivery market players are listed below.

In March 2026, SHL Medical AG, the global leader in advanced drug delivery solutions, announced a strategic collaboration with Thermo Fisher Scientific Inc., the world leader in serving science. The collaboration will provide end-to-end offering of sterile fill-finish and device final assembly at Thermo Fisher?s site in Ridgefield, New Jersey, USA.

In January 2026, BD and Ypsomed announced an enhanced collaboration to develop a 5.5 mL BD Neopak XtraFlow Glass Prefillable Syringe compatible with Ypsomed's YpsoMate 5.5 autoinjector platform. This innovation aims to support large-volume, high-viscosity biologic self-injection by improving flow efficiency and reducing injection time. The move responds to growing demand for patient-friendly self-administration of complex therapies. Development and feasibility samples are expected by mid-2026.

Table Of Contents

1. Executive Summary

  • 1.1 Analyst Market Outlook
  • 1.2 Market Attractiveness

2. Long-Term Injectable Drug Delivery Market Landscape

  • 2.1 Overview
  • 2.2 Value Chain Analysis
  • 2.3 Supply Chain Analysis
    • 2.3.1 List of Manufacturers/Suppliers
    • 2.3.2 List of Potential Customers (Upto 50)
  • 2.4 Porter's Five Force Analysis
  • 2.5 PEST Analysis
  • 2.6 Import-Export Analysis for Key Countries (As per the nearest HS Code)
    • 2.6.1 Import-Export Analysis for Key Countries
  • 2.7 Impact of Artificial Intelligence (AI)
  • 2.8 Product or Technology Roadmap
  • 2.9 Sustainability and ESG Trends
  • 2.10 Patent Analysis
  • 2.11 Regulatory Framework

3. Competitive Landscape

  • 3.1 Company Benchmarking by Key Players
  • 3.2 Market Share Analysis, 2025 - By Key Players
  • 3.3 Market Concentration

4. Long-Term Injectable Drug Delivery Market - Key Industry Dynamics

  • 4.1 Market Drivers
  • 4.2 Market Restraints
  • 4.3 Market Opportunities
  • 4.4 Future Trends
  • 4.5 Impact of Drivers and Restraints

5. Long-Term Injectable Drug Delivery Market - Global Market Analysis

  • 5.1 Long-Term Injectable Drug Delivery Market Revenue (US$ Million), 2021-2034
  • 5.2 Long-Term Injectable Drug Delivery Market Forecast and Analysis

6. Long-Term Injectable Drug Delivery Market Revenue Analysis - Formulation Packaging (ready-to-use)

  • 6.1 Long-Term Injectable Drug Delivery Market Forecasts and Analysis by Formulation Packaging (ready-to-use)
    • 6.1.1 Ampoules
      • 6.1.1.1 Overview
      • 6.1.1.2 Ampoules: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.2 Vials
      • 6.1.2.1 Overview
      • 6.1.2.2 Vials: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.3 Cartridges
      • 6.1.3.1 Overview
      • 6.1.3.2 Cartridges: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.4 Bottles
      • 6.1.4.1 Overview
      • 6.1.4.2 Bottles: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2034 (US$ Million)

7. Long-Term Injectable Drug Delivery Market Revenue Analysis - Therapeutic Application

  • 7.1 Long-Term Injectable Drug Delivery Market Forecasts and Analysis by Therapeutic Application
    • 7.1.1 Diabetes
      • 7.1.1.1 Overview
      • 7.1.1.2 Diabetes: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.2 Oncology
      • 7.1.2.1 Overview
      • 7.1.2.2 Oncology: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.3 Auto-Immune Disorders
      • 7.1.3.1 Overview
      • 7.1.3.2 Auto-Immune Disorders: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.4 Cardiovascular Diseases
      • 7.1.4.1 Overview
      • 7.1.4.2 Cardiovascular Diseases: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.5 Infectious Diseases
      • 7.1.5.1 Overview
      • 7.1.5.2 Infectious Diseases: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.6 Pain Management
      • 7.1.6.1 Overview
      • 7.1.6.2 Pain Management: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.7 Others
      • 7.1.7.1 Overview
      • 7.1.7.2 Others: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2034 (US$ Million)

8. Long-Term Injectable Drug Delivery Market Revenue Analysis - Route Of Administration

  • 8.1 Long-Term Injectable Drug Delivery Market Forecasts and Analysis by Route Of Administration
    • 8.1.1 Subcutaneous
      • 8.1.1.1 Overview
      • 8.1.1.2 Subcutaneous: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.2 Intramuscular
      • 8.1.2.1 Overview
      • 8.1.2.2 Intramuscular: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.3 Intravenous
      • 8.1.3.1 Overview
      • 8.1.3.2 Intravenous: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.4 Others
      • 8.1.4.1 Overview
      • 8.1.4.2 Others: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2034 (US$ Million)

9. Long-Term Injectable Drug Delivery Market Revenue Analysis - Usability

  • 9.1 Long-Term Injectable Drug Delivery Market Forecasts and Analysis by Usability
    • 9.1.1 Disposable Injectors
      • 9.1.1.1 Overview
      • 9.1.1.2 Disposable Injectors: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2034 (US$ Million)
    • 9.1.2 Re-usable Injectors
      • 9.1.2.1 Overview
      • 9.1.2.2 Re-usable Injectors: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2034 (US$ Million)

10. Long-Term Injectable Drug Delivery Market Revenue Analysis - End User

  • 10.1 Long-Term Injectable Drug Delivery Market Forecasts and Analysis by End User
    • 10.1.1 Pharmaceutical and Biopharma Companies
      • 10.1.1.1 Overview
      • 10.1.1.2 Pharmaceutical and Biopharma Companies: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2034 (US$ Million)
    • 10.1.2 CMOs and CDMOs
      • 10.1.2.1 Overview
      • 10.1.2.2 CMOs and CDMOs: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2034 (US$ Million)

11. Long-Term Injectable Drug Delivery Market - Geographical Analysis

  • 11.1 North America
    • 11.1.1 North America Long-Term Injectable Drug Delivery Market Overview
    • 11.1.2 North America: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 11.1.3 North America: Long-Term Injectable Drug Delivery Market - By Segmentation
      • 11.1.3.1 Formulation Packaging (ready-to-use)
      • 11.1.3.2 Therapeutic Application
      • 11.1.3.3 Route Of Administration
      • 11.1.3.4 Usability
      • 11.1.3.5 End User
    • 11.1.4 North America: Long-Term Injectable Drug Delivery Market Breakdown by Countries
      • 11.1.4.1 United States Market
        • 11.1.4.1.1 United States: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.1.4.1.2 United States: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.1.4.1.2.1 Formulation Packaging (ready-to-use)
          • 11.1.4.1.2.2 Therapeutic Application
          • 11.1.4.1.2.3 Route Of Administration
          • 11.1.4.1.2.4 Usability
          • 11.1.4.1.2.5 End User
      • 11.1.4.2 Canada Market
        • 11.1.4.2.1 Canada: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.1.4.2.2 Canada: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.1.4.2.2.1 Formulation Packaging (ready-to-use)
          • 11.1.4.2.2.2 Therapeutic Application
          • 11.1.4.2.2.3 Route Of Administration
          • 11.1.4.2.2.4 Usability
          • 11.1.4.2.2.5 End User
      • 11.1.4.3 Mexico Market
        • 11.1.4.3.1 Mexico: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.1.4.3.2 Mexico: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.1.4.3.2.1 Formulation Packaging (ready-to-use)
          • 11.1.4.3.2.2 Therapeutic Application
          • 11.1.4.3.2.3 Route Of Administration
          • 11.1.4.3.2.4 Usability
          • 11.1.4.3.2.5 End User
  • 11.2 Europe
    • 11.2.1 Europe Long-Term Injectable Drug Delivery Market Overview
    • 11.2.2 Europe: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 11.2.3 Europe: Long-Term Injectable Drug Delivery Market - By Segmentation
      • 11.2.3.1 Formulation Packaging (ready-to-use)
      • 11.2.3.2 Therapeutic Application
      • 11.2.3.3 Route Of Administration
      • 11.2.3.4 Usability
      • 11.2.3.5 End User
    • 11.2.4 Europe: Long-Term Injectable Drug Delivery Market Breakdown by Countries
      • 11.2.4.1 Germany Market
        • 11.2.4.1.1 Germany: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.2.4.1.2 Germany: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.2.4.1.2.1 Formulation Packaging (ready-to-use)
          • 11.2.4.1.2.2 Therapeutic Application
          • 11.2.4.1.2.3 Route Of Administration
          • 11.2.4.1.2.4 Usability
          • 11.2.4.1.2.5 End User
      • 11.2.4.2 United Kingdom Market
        • 11.2.4.2.1 United Kingdom: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.2.4.2.2 United Kingdom: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.2.4.2.2.1 Formulation Packaging (ready-to-use)
          • 11.2.4.2.2.2 Therapeutic Application
          • 11.2.4.2.2.3 Route Of Administration
          • 11.2.4.2.2.4 Usability
          • 11.2.4.2.2.5 End User
      • 11.2.4.3 France Market
        • 11.2.4.3.1 France: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.2.4.3.2 France: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.2.4.3.2.1 Formulation Packaging (ready-to-use)
          • 11.2.4.3.2.2 Therapeutic Application
          • 11.2.4.3.2.3 Route Of Administration
          • 11.2.4.3.2.4 Usability
          • 11.2.4.3.2.5 End User
      • 11.2.4.4 Spain Market
        • 11.2.4.4.1 Spain: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.2.4.4.2 Spain: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.2.4.4.2.1 Formulation Packaging (ready-to-use)
          • 11.2.4.4.2.2 Therapeutic Application
          • 11.2.4.4.2.3 Route Of Administration
          • 11.2.4.4.2.4 Usability
          • 11.2.4.4.2.5 End User
      • 11.2.4.5 Italy Market
        • 11.2.4.5.1 Italy: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.2.4.5.2 Italy: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.2.4.5.2.1 Formulation Packaging (ready-to-use)
          • 11.2.4.5.2.2 Therapeutic Application
          • 11.2.4.5.2.3 Route Of Administration
          • 11.2.4.5.2.4 Usability
          • 11.2.4.5.2.5 End User
      • 11.2.4.6 Rest of Europe Market
        • 11.2.4.6.1 Rest of Europe: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.2.4.6.2 Rest of Europe: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.2.4.6.2.1 Formulation Packaging (ready-to-use)
          • 11.2.4.6.2.2 Therapeutic Application
          • 11.2.4.6.2.3 Route Of Administration
          • 11.2.4.6.2.4 Usability
          • 11.2.4.6.2.5 End User
  • 11.3 Asia Pacific
    • 11.3.1 Asia Pacific Long-Term Injectable Drug Delivery Market Overview
    • 11.3.2 Asia Pacific: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 11.3.3 Asia Pacific: Long-Term Injectable Drug Delivery Market - By Segmentation
      • 11.3.3.1 Formulation Packaging (ready-to-use)
      • 11.3.3.2 Therapeutic Application
      • 11.3.3.3 Route Of Administration
      • 11.3.3.4 Usability
      • 11.3.3.5 End User
    • 11.3.4 Asia Pacific: Long-Term Injectable Drug Delivery Market Breakdown by Countries
      • 11.3.4.1 China Market
        • 11.3.4.1.1 China: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.3.4.1.2 China: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.3.4.1.2.1 Formulation Packaging (ready-to-use)
          • 11.3.4.1.2.2 Therapeutic Application
          • 11.3.4.1.2.3 Route Of Administration
          • 11.3.4.1.2.4 Usability
          • 11.3.4.1.2.5 End User
      • 11.3.4.2 Japan Market
        • 11.3.4.2.1 Japan: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.3.4.2.2 Japan: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.3.4.2.2.1 Formulation Packaging (ready-to-use)
          • 11.3.4.2.2.2 Therapeutic Application
          • 11.3.4.2.2.3 Route Of Administration
          • 11.3.4.2.2.4 Usability
          • 11.3.4.2.2.5 End User
      • 11.3.4.3 India Market
        • 11.3.4.3.1 India: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.3.4.3.2 India: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.3.4.3.2.1 Formulation Packaging (ready-to-use)
          • 11.3.4.3.2.2 Therapeutic Application
          • 11.3.4.3.2.3 Route Of Administration
          • 11.3.4.3.2.4 Usability
          • 11.3.4.3.2.5 End User
      • 11.3.4.4 Australia Market
        • 11.3.4.4.1 Australia: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.3.4.4.2 Australia: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.3.4.4.2.1 Formulation Packaging (ready-to-use)
          • 11.3.4.4.2.2 Therapeutic Application
          • 11.3.4.4.2.3 Route Of Administration
          • 11.3.4.4.2.4 Usability
          • 11.3.4.4.2.5 End User
      • 11.3.4.5 South Korea Market
        • 11.3.4.5.1 South Korea: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.3.4.5.2 South Korea: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.3.4.5.2.1 Formulation Packaging (ready-to-use)
          • 11.3.4.5.2.2 Therapeutic Application
          • 11.3.4.5.2.3 Route Of Administration
          • 11.3.4.5.2.4 Usability
          • 11.3.4.5.2.5 End User
      • 11.3.4.6 Rest of Asia Pacific Market
        • 11.3.4.6.1 Rest of Asia Pacific: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.3.4.6.2 Rest of Asia Pacific: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.3.4.6.2.1 Formulation Packaging (ready-to-use)
          • 11.3.4.6.2.2 Therapeutic Application
          • 11.3.4.6.2.3 Route Of Administration
          • 11.3.4.6.2.4 Usability
          • 11.3.4.6.2.5 End User
  • 11.4 Middle East and Africa
    • 11.4.1 Middle East and Africa Long-Term Injectable Drug Delivery Market Overview
    • 11.4.2 Middle East and Africa: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 11.4.3 Middle East and Africa: Long-Term Injectable Drug Delivery Market - By Segmentation
      • 11.4.3.1 Formulation Packaging (ready-to-use)
      • 11.4.3.2 Therapeutic Application
      • 11.4.3.3 Route Of Administration
      • 11.4.3.4 Usability
      • 11.4.3.5 End User
    • 11.4.4 Middle East and Africa: Long-Term Injectable Drug Delivery Market Breakdown by Countries
      • 11.4.4.1 Saudi Arabia Market
        • 11.4.4.1.1 Saudi Arabia: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.4.4.1.2 Saudi Arabia: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.4.4.1.2.1 Formulation Packaging (ready-to-use)
          • 11.4.4.1.2.2 Therapeutic Application
          • 11.4.4.1.2.3 Route Of Administration
          • 11.4.4.1.2.4 Usability
          • 11.4.4.1.2.5 End User
      • 11.4.4.2 South Africa Market
        • 11.4.4.2.1 South Africa: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.4.4.2.2 South Africa: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.4.4.2.2.1 Formulation Packaging (ready-to-use)
          • 11.4.4.2.2.2 Therapeutic Application
          • 11.4.4.2.2.3 Route Of Administration
          • 11.4.4.2.2.4 Usability
          • 11.4.4.2.2.5 End User
      • 11.4.4.3 United Arab Emirates Market
        • 11.4.4.3.1 United Arab Emirates: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.4.4.3.2 United Arab Emirates: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.4.4.3.2.1 Formulation Packaging (ready-to-use)
          • 11.4.4.3.2.2 Therapeutic Application
          • 11.4.4.3.2.3 Route Of Administration
          • 11.4.4.3.2.4 Usability
          • 11.4.4.3.2.5 End User
      • 11.4.4.4 Rest of Middle East and Africa Market
        • 11.4.4.4.1 Rest of Middle East and Africa: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.4.4.4.2 Rest of Middle East and Africa: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.4.4.4.2.1 Formulation Packaging (ready-to-use)
          • 11.4.4.4.2.2 Therapeutic Application
          • 11.4.4.4.2.3 Route Of Administration
          • 11.4.4.4.2.4 Usability
          • 11.4.4.4.2.5 End User
  • 11.5 South and Central America
    • 11.5.1 South and Central America Long-Term Injectable Drug Delivery Market Overview
    • 11.5.2 South and Central America: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 11.5.3 South and Central America: Long-Term Injectable Drug Delivery Market - By Segmentation
      • 11.5.3.1 Formulation Packaging (ready-to-use)
      • 11.5.3.2 Therapeutic Application
      • 11.5.3.3 Route Of Administration
      • 11.5.3.4 Usability
      • 11.5.3.5 End User
    • 11.5.4 South and Central America: Long-Term Injectable Drug Delivery Market Breakdown by Countries
      • 11.5.4.1 Brazil Market
        • 11.5.4.1.1 Brazil: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.5.4.1.2 Brazil: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.5.4.1.2.1 Formulation Packaging (ready-to-use)
          • 11.5.4.1.2.2 Therapeutic Application
          • 11.5.4.1.2.3 Route Of Administration
          • 11.5.4.1.2.4 Usability
          • 11.5.4.1.2.5 End User
      • 11.5.4.2 Argentina Market
        • 11.5.4.2.1 Argentina: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.5.4.2.2 Argentina: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.5.4.2.2.1 Formulation Packaging (ready-to-use)
          • 11.5.4.2.2.2 Therapeutic Application
          • 11.5.4.2.2.3 Route Of Administration
          • 11.5.4.2.2.4 Usability
          • 11.5.4.2.2.5 End User
      • 11.5.4.3 Rest of South and Central America Market
        • 11.5.4.3.1 Rest of South and Central America: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 11.5.4.3.2 Rest of South and Central America: Long-Term Injectable Drug Delivery Market - By Segmentation
          • 11.5.4.3.2.1 Formulation Packaging (ready-to-use)
          • 11.5.4.3.2.2 Therapeutic Application
          • 11.5.4.3.2.3 Route Of Administration
          • 11.5.4.3.2.4 Usability
          • 11.5.4.3.2.5 End User

12. Long-Term Injectable Drug Delivery Market Industry Landscape

13. Long-Term Injectable Drug Delivery Market - Key Company Profiles

  • 13.1 Becton Dickinson and Co
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Schott AG
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Phillips-Medisize
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Gerresheimer AG
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 West Pharmaceutical Services Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Terumo Corp
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 SHL Medical
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Ypsomed Holding AG
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Owen Mumford Ltd
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 AptarGroup Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. List of Additional Companies Analyzed

  • 14.1 List of Additional Companies Analyzed

15. Appendix

  • 15.1 Glossary
  • 15.2 Research Methodology and Approach
    • 15.2.1 Secondary Research
    • 15.2.2 Primary Research
    • 15.2.3 Market Estimation Approach
      • 15.2.3.1 Supply Side Analysis
      • 15.2.3.2 Demand Side Analysis
    • 15.2.4 Research Assumptions and Limitations
    • 15.2.5 Currency Conversion
  • 15.3 About The Insight Partners
  • 15.4 Market Intelligence Cloud

List Of Tables

  • Table 1. Long-Term Injectable Drug Delivery Market Segmentation. 2
  • Table 2. List of Patents and Description
  • Table 3. List of Regulatory Bodies and Organizations
  • Table 4. Ease of Doing Business: Key Country Rankings
  • Table 5. Market Share Analysis, 2025 - By Key Players
  • Table 6. Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million)
  • Table 7. Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million)
  • Table 8. Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 9. Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 10. Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 11. Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 12. Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 13. Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 14. Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 15. Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 16. Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 17. Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 18. North America: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 19. North America: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 20. North America: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 21. North America: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 22. North America: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 23. North America: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 24. North America: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 25. North America: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 26. North America: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 27. North America: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 28. North America: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Country
  • Table 29. North America: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
  • Table 30. United States: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 31. United States: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 32. United States: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 33. United States: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 34. United States: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 35. United States: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 36. United States: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 37. United States: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 38. United States: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 39. United States: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 40. Canada: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 41. Canada: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 42. Canada: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 43. Canada: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 44. Canada: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 45. Canada: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 46. Canada: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 47. Canada: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 48. Canada: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 49. Canada: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 50. Mexico: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 51. Mexico: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 52. Mexico: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 53. Mexico: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 54. Mexico: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 55. Mexico: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 56. Mexico: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 57. Mexico: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 58. Mexico: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 59. Mexico: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 60. Europe: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 61. Europe: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 62. Europe: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 63. Europe: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 64. Europe: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 65. Europe: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 66. Europe: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 67. Europe: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 68. Europe: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 69. Europe: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 70. Europe: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Country
  • Table 71. Europe: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
  • Table 72. Germany: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 73. Germany: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 74. Germany: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 75. Germany: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 76. Germany: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 77. Germany: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 78. Germany: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 79. Germany: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 80. Germany: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 81. Germany: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 82. United Kingdom: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 83. United Kingdom: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 84. United Kingdom: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 85. United Kingdom: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 86. United Kingdom: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 87. United Kingdom: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 88. United Kingdom: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 89. United Kingdom: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 90. United Kingdom: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 91. United Kingdom: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 92. France: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 93. France: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 94. France: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 95. France: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 96. France: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 97. France: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 98. France: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 99. France: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 100. France: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 101. France: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 102. Spain: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 103. Spain: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 104. Spain: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 105. Spain: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 106. Spain: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 107. Spain: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 108. Spain: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 109. Spain: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 110. Spain: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 111. Spain: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 112. Italy: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 113. Italy: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 114. Italy: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 115. Italy: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 116. Italy: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 117. Italy: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 118. Italy: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 119. Italy: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 120. Italy: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 121. Italy: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 122. Rest of Europe: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 123. Rest of Europe: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 124. Rest of Europe: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 125. Rest of Europe: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 126. Rest of Europe: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 127. Rest of Europe: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 128. Rest of Europe: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 129. Rest of Europe: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 130. Rest of Europe: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 131. Rest of Europe: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 132. Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 133. Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 134. Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 135. Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 136. Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 137. Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 138. Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 139. Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 140. Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 141. Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 142. Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Country
  • Table 143. Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
  • Table 144. China: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 145. China: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 146. China: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 147. China: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 148. China: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 149. China: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 150. China: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 151. China: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 152. China: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 153. China: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 154. Japan: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 155. Japan: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 156. Japan: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 157. Japan: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 158. Japan: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 159. Japan: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 160. Japan: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 161. Japan: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 162. Japan: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 163. Japan: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 164. India: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 165. India: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 166. India: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 167. India: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 168. India: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 169. India: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 170. India: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 171. India: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 172. India: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 173. India: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 174. Australia: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 175. Australia: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 176. Australia: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 177. Australia: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 178. Australia: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 179. Australia: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 180. Australia: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 181. Australia: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 182. Australia: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 183. Australia: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 184. South Korea: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 185. South Korea: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 186. South Korea: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 187. South Korea: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 188. South Korea: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 189. South Korea: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 190. South Korea: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 191. South Korea: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 192. South Korea: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 193. South Korea: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 194. Rest of Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 195. Rest of Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 196. Rest of Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 197. Rest of Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 198. Rest of Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 199. Rest of Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 200. Rest of Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 201. Rest of Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 202. Rest of Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 203. Rest of Asia Pacific: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 204. Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 205. Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 206. Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 207. Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 208. Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 209. Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 210. Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 211. Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 212. Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 213. Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 214. Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Country
  • Table 215. Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
  • Table 216. Saudi Arabia: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 217. Saudi Arabia: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 218. Saudi Arabia: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 219. Saudi Arabia: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 220. Saudi Arabia: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 221. Saudi Arabia: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 222. Saudi Arabia: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 223. Saudi Arabia: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 224. Saudi Arabia: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 225. Saudi Arabia: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 226. South Africa: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 227. South Africa: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 228. South Africa: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 229. South Africa: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 230. South Africa: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 231. South Africa: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 232. South Africa: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 233. South Africa: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 234. South Africa: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 235. South Africa: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 236. United Arab Emirates: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 237. United Arab Emirates: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 238. United Arab Emirates: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 239. United Arab Emirates: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 240. United Arab Emirates: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 241. United Arab Emirates: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 242. United Arab Emirates: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 243. United Arab Emirates: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 244. United Arab Emirates: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 245. United Arab Emirates: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 246. Rest of Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 247. Rest of Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Formulation Packaging (ready-to-use)
  • Table 248. Rest of Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Therapeutic Application
  • Table 249. Rest of Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Therapeutic Application
  • Table 250. Rest of Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Route Of Administration
  • Table 251. Rest of Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Route Of Administration
  • Table 252. Rest of Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 253. Rest of Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 254. Rest of Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 255. Rest of Middle East and Africa: Long-Term Injectable Drug Delivery Market - Revenue Forecast, 2026-2034 (US$ Million) - by End Us

List Of Figures

  • Figure 1. Long-Term Injectable Drug Delivery Market - Value Chain Analysis
  • Figure 2. Porter's Five Forces Analysis
  • Figure 3. Pest Analysis
  • Figure 4. Long-Term Injectable Drug Delivery Market - Key Industry Dynamics
  • Figure 5. Impact Analysis of Drivers and Restraints
  • Figure 6. Long-Term Injectable Drug Delivery Market Revenue (US$ Million), 2021-2034
  • Figure 7. Long-Term Injectable Drug Delivery Market Share (%) - by Formulation Packaging (ready-to-use) (2025 and 2034)
  • Figure 8. Ampoules: Long-Term Injectable Drug Delivery Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 9. Vials: Long-Term Injectable Drug Delivery Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 10. Cartridges: Long-Term Injectable Drug Delivery Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 11. Bottles: Long-Term Injectable Drug Delivery Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 12. Long-Term Injectable Drug Delivery Market Share (%) - by Therapeutic Application (2025 and 2034)
  • Figure 13. Diabetes: Long-Term Injectable Drug Delivery Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 14. Oncology: Long-Term Injectable Drug Delivery Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 15. Auto-Immune Disorders: Long-Term Injectable Drug Delivery Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 16. Cardiovascular Diseases: Long-Term Injectable Drug Delivery Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 17. Infectious Diseases: Long-Term Injectable Drug Delivery Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 18. Pain Management: Long-Term Injectable Drug Delivery Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 19. Others: Long-Term Injectable Drug Delivery Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 20. Long-Term Injectable Drug Delivery Market Share (%) - by Route Of Administration (2025 and 2034)
  • Figure 21. Subcutaneous: Long-Term Injectable Drug Delivery Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 22. Intramuscular: Long-Term Injectable Drug Delivery Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 23. Intravenous: Long-Term Injectable Drug Delivery Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 24. Others: Long-Term Injectable Drug Delivery Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 25. Long-Term Injectable Drug Delivery Market Share (%) - by Usability (2025 and 2034)
  • Figure 26. Disposable Injectors: Long-Term Injectable Drug Delivery Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 27. Re-usable Injectors: Long-Term Injectable Drug Delivery Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 28. Long-Term Injectable Drug Delivery Market Share (%) - by End User (2025 and 2034)
  • Figure 29. Pharmaceutical and Biopharma Companies: Long-Term Injectable Drug Delivery Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 30. CMOs and CDMOs: Long-Term Injectable Drug Delivery Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 31. Long-Term Injectable Drug Delivery Market Breakdown by Geography, 2025 and 2034
  • Figure 32. North America: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 33. North America: Long-Term Injectable Drug Delivery Market Breakdown by Key Countries, 2025 and 2034 (%)
  • Figure 34. United States: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 35. Canada: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 36. Mexico: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 37. Europe: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 38. Europe: Long-Term Injectable Drug Delivery Market Breakdown by Key Countries, 2025 and 2034 (%)
  • Figure 39. Germany: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 40. United Kingdom: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 41. France: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 42. Spain: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 43. Italy: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 44. Rest of Europe: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 45. Asia Pacific: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 46. Asia Pacific: Long-Term Injectable Drug Delivery Market Breakdown by Key Countries, 2025 and 2034 (%)
  • Figure 47. China: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 48. Japan: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 49. India: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 50. Australia: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 51. South Korea: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 52. Rest of Asia Pacific: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 53. Middle East and Africa: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 54. Middle East and Africa: Long-Term Injectable Drug Delivery Market Breakdown by Key Countries, 2025 and 2034 (%)
  • Figure 55. Saudi Arabia: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 56. South Africa: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 57. United Arab Emirates: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 58. Rest of Middle East and Africa: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 59. South and Central America: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 60. South and Central America: Long-Term Injectable Drug Delivery Market Breakdown by Key Countries, 2025 and 2034 (%)
  • Figure 61. Brazil: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 62. Argentina: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 63. Rest of South and Central America: Long-Term Injectable Drug Delivery Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 64. Bottom-Up Approach and Top-Down Approach